DrugDashboards

Cisatracurium Besylate

Cisatracurium Besylate · CISATRACURIUM BESYLATE 200 mg/20mL · Injection · Intravenous · Armas Pharmaceuticals

NDC 72485-0513-10 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$400.00
Reported to Texas DSHS · 2026 annual filing · Armas Pharmaceuticals, Inc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA217725
TE code
AP
Approval date
Jun 9, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Cisatracurium Besylate (Injection)

LabelerStrengthFirst seenLast seen
Camber Pharmaceuticals Inc.CISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Sep 3, 2026
Caplin Steriles LimitedCISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Sep 3, 2026
Slate Run Pharmaceuticals, LLCCISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Sep 3, 2026
Somerset Therapeutics, LLCCISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Sep 3, 2026
Armas PharmaceuticalsCISATRACURIUM BESYLATE 200 mg/20mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals Inc.CISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedCISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCCISATRACURIUM BESYLATE 10 mg/5mLJul 15, 2026Sep 2, 2026
Eugia US LLCCISATRACURIUM BESYLATE 20 mg/10mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedCISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncCISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCCISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCCISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedCISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.CISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.CISATRACURIUM BESYLATE 10 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedCISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Aug 31, 2026
Hikma Pharmaceuticals USA Inc.CISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Aug 31, 2026
Sandoz IncCISATRACURIUM BESYLATE 2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cisatracurium Besylate — NDC 72485-0513-10," retrieved September 3, 2026, https://drugdashboards.com/drug/72485051310.

Free to cite with attribution — see how the data is put together.